Capricor Therapeutics Inc (NASDAQ: CAPR) stock enjoyed a major increase of 13.5% on 9/5/25. The shares closed at $6.74. Trading volume in this advance was normal. The stock has been extremely weak relative to the market over the last nine months but has risen 7.8% during the last week.
Current PriceTarget Research Rating
Capricor Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Capricor Therapeutics has a neutral Appreciation Score of 43 but a very low Power Rating of 4, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment